VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
18 hedge funds and large institutions have $47.5M invested in Verona Pharma in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$113K |
| 2 |
Renaissance Technologies
New York
|
+$76K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$69.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$68K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$35.3K |
Top Sellers
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.99M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$415 |
